- $600 MnWorld market, 2023
- $6.1 BnProjected, 2033
- 26.1%Growth a year (CAGR)
- 658Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$252 Mn
24.1% a year · 42% of the world -
2
China
$48 Mn
27.6% a year · 8% of the world -
3
Canada
$48 Mn
26.1% a year · 8% of the world -
4
Japan
$37 Mn
26.6% a year · 6.2% of the world -
5
Germany
$22 Mn
24.3% a year · 3.7% of the world -
6
France
$17 Mn
25.1% a year · 2.8% of the world -
7
UK
$16 Mn
24.1% a year · 2.6% of the world -
8
Brazil
$15 Mn
27.1% a year · 2.5% of the world -
9
Italy
$14 Mn
25.6% a year · 2.4% of the world -
10
Ecuador
$12 Mn
26.7% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainArtificial Intelligence (AI) in Drugs Discovery by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 5,789 papers since 2021
- Pocket-sized drug discovery: An AI-empowered smartphone platform coupled with single-atom nanozymes for on-site inhibitor screening. Analytica chimica acta, 2026
- GPCRAgent: an intelligent multi-agent platform integrating knowledge graphs and large language models for GPCR-targeted drug discovery. Journal of advanced research, 2026
- Graphics processing unit-accelerated quantum simulation for molecular biology and drug discovery: algorithms, platforms, and emerging applications. Briefings in bioinformatics, 2026
- QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery. Journal of chemical information and modeling, 2026
- AI-Driven Discovery Pipeline Identifies Carvedilol as a Novel Partial Agonist of THRβ. Journal of chemical information and modeling, 2026
Compare Artificial Intelligence (AI) in Drugs Discovery side by side
Key companies in Artificial Intelligence (AI) in Drugs Discovery
Exscientia
Insilico Medicine
Schrödinger
Cyclica
IBM Watson Health
GNS Healthcare
BERG Health
Numerate
Quick answers
How big is the Artificial Intelligence (AI) in Drugs Discovery market?
The world Artificial Intelligence (AI) in Drugs Discovery market was worth about $600 Mn in 2023 and is projected to reach $6.1 Bn by 2033, growing 26.1% a year (CAGR).
Which country has the largest Artificial Intelligence (AI) in Drugs Discovery market?
The US is the largest of the 24 countries we cover, at $252 Mn in 2023. India grows fastest, at 29.1% a year.
How many clinical trials are running in Artificial Intelligence (AI) in Drugs Discovery?
ClinicalTrials.gov lists 658 active trials worldwide (recruiting, about to start or running), most of them in China, as of 10 Nov 2026.
How much research is published on Artificial Intelligence (AI) in Drugs Discovery?
PubMed lists about 5,789 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.